The 3D Brain Unit Network Model to Study Spatial Brain Drug Exposure under Healthy and Pathological Conditions

• DOI: 10.1007/s11095-020-2760-y
• Publication Date: 2020-07-09T21:07:00Z
• Authors: Esmée Vendel; Vivi Rottschäfer; Elizabeth C.M. de...
• Keywords: 0301 basic medicine; Microcirculation; Biological Availability; Brain; Biological Transport; Models, Biological; Capillary Permeability; 03 medical and health sciences; Pharmaceutical Preparations; Blood-Brain Barrier; Cerebrovascular Circulation; Humans; Computer Simulation; Tissue Distribution; Research Paper; Protein Binding

Abstract Purpose We have developed a 3D brain unit network model to understand the spatial-temporal distribution of a drug within the brain under different (normal and disease) conditions. Our main aim is to study the impact of disease-induced changes in drug transport processes on spatial drug distribution within the brain extracellular fluid (ECF).

Methods The 3D brain unit network consists of multiple connected single 3D brain units in which the brain capillaries surround the brain ECF. The model includes the distribution of unbound drug within blood plasma, coupled with the distribution of drug within brain ECF and incorporates brain capillaryblood flow, passive paracellular and transcellular BBB transport, active BBB transport, brain ECF diffusion, brain ECF bulk flow, and specific and nonspecific brain tissue binding. All of these processes may change under disease conditions.

Results We show that the simulated disease-induced changes in brain tissue characteristics significantly affect drug concentrations within the brain ECF.

Conclusions We demonstrate that the 3D brain unit network model is an excellent tool to gain understanding in the interdependencies of the factors governing spatial-temporal drug concentrations within the brain ECF. Additionally, the model helps in predicting the spatial-temporal brain ECF concentrations of existing drugs, under both normal and disease conditions.